Phaarmasia (BOM:523620) Margin of Safety % (DCF Earnings Based): N/A (As of Jul. 08, 2026)


BOM:523620 Phaarmasia Ltd BOM:523620
62 GF Score
Price ₹98.74
GF Value ₹67.48
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Phaarmasia Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Phaarmasia's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

BOM:523620 vs ZTS, UTHR: Margin of Safety % (DCF Earnings Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Phaarmasia's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Phaarmasia Margin of Safety % (DCF Earnings Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Phaarmasia's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Phaarmasia's Margin of Safety % (DCF Earnings Based) falls into.


BOM:523620
62GF Score
Phaarmasia Ltd BOM:523620
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Phaarmasia (BOM:523620) Overvalued in 2026?

Based on GuruFocus' analysis, Phaarmasia stock appears to be overvalued. The current stock price of ₹98.74 is trading 46.3% above its estimated GF Value™ of ₹67.48. GuruFocus considers Phaarmasia to be Significantly Overvalued.

Key valuation signals for BOM:523620:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: ₹67.48 vs. price of ₹98.74 (46.3% above fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the BOM:523620 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Phaarmasia Business Description

Address Plot No. 16, Phase III, IDA, Jeedimetla, Hyderabad, TG, IND, 500055
Phaarmasia Ltd is a pharmaceutical company based in India. It is engaged in the manufacturing of Oral Contraceptive Pills and Combipack with Iron tablets. It offers hormone and herbal products. The company operates in one operating segment namely, Manufacturing and sale of OCPs, and derives prime revenue from India.
62GF Score

Get the complete analysis for BOM:523620

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹98.74
Price
₹67.48
GF Value